Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00584714 · ClinicalTrials.gov registry record
Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent
A clinical trial, sponsored by Point Biomedical.
- Terminated
- Registry status
- 300
- Enrollment target
NCT00584714: Clinical Trial study, sponsored by Point Biomedical.
NCT00584714 is a clinical trial that was terminated before completion, run by Point Biomedical. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00584714 was terminated before completion, sponsored by Point Biomedical.
- TERMINATED
- Registry status
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-07 |
Why NCT00584714 stopped before completion
NCT00584714 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00584714 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00584714 about?
NCT00584714 is a clinical study titled "Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent". The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).
What is the current status of trial NCT00584714?
This trial is currently terminated. The enrollment target is 300 participants. The study started on 2007-10. Estimated completion is 2008-07.
Who is sponsoring clinical trial NCT00584714?
This trial is sponsored by Point Biomedical, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia